Relationship between ApoE, MRI findings, and cognitive function in the cardiovascular health study

Stroke

Volumn 29, Issue 2, 1998, Pages 388-398

  Kuller, Lewis H ^h   Shemanski, Lynn ^a   Manolio, Teri ^b   Haan, Mary ^c   Fried, Linda ^d   Bryan, Nick ^b   Burke, Gregory L ^e   Tracy, Russell ^f   Bhadelia, Rafeeque ^g  

^a CHS Coordinating Center   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF VERMONT   (United States)

^g TUFTS MEDICAL CENTER   (United States)

^h UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Apolipoproteins; Dementia; Magnetic resonance imaging; Stroke; Vascular disease

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; COGNITION; DEMENTIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; STROKE;

EID: 0031910347     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.2.388     Document Type: Article

References (70)

1. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry. 1987;48:314-318.
2. Teng EL, Chui HC, Gong A. Comparisons between the Mini-Mental State Exam (MMSE) and its modified version-the 3MS test. In: Hasegawa K, Homma A, eds. Psychogeriatrics Biomedical and Social Advances. Amsterdam/Princeton/Hong Kong/Tokyo/Sydney: Excerpta Medica; 1990:189-192.
3. Bryan RN, Manolio TA, Schertz LD, Jungreis C, Poirier VC, Elster AD, Kronmal RA. A method for using MR to evaluate the effects of cardiovascular disease on the brain: the Cardiovascular Health Study. Am J Neuroradiol. 1994;15:1625-1633.
4. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amanducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
5. Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A. Prevalence of Alzheimer's disease and vascular dementia: association with education: the Rotterdam Study. BMJ. 1995; 310:970-973.
6. Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology. 1995;14:240-257.
7. Emery VO, Gillie EX, Ramdev PT. Noninfarct vascular dementia: a new subtype. J Clin Geropsychol. 1996;2:197-213.
8. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology. 1996;19:154-159.
9. Prencipe M, Ferretti C, Casini AR, Santini M, Giublei F, Culasso F. Stroke, disability, and dementia: results of a population survey. Stroke. 1997;28:531-536.
10. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia three months after stroke: baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997;28:785-792.
11. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Pirro M, Hanzawa LK. Dementia after stroke is a predictor of long-term survival. Stroke. 1994;25: 1915-1919.
12. Hamos JE, DeGennaro LJ, Drachman DA. Synaptic loss in Alzheimer's disease and other dementias. Neurology. 1989;39:355-361.
13. Jagust WJ. Functional imaging patterns in Alzheimer's disease: relationships to neurobiology. Ann N Y Acad Sci. 1996;777:30-36.
14. Coffey CE, Wilkinson WE, Parashos IA, Soady SAR, Sullivan RJ, Patterson LJ, Figil GS, Webb MC, Spritzer CE, Djang WT. Quantitative cerebral anatomy of the aging brain: a cross-sectional study using magnetic resonance imaging. Neurology. 1992;42:527-536.
15. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet. 1996;348:94-97.
16. Jobst KA, Smith AD, Szatmari M, Esiri MM, Jaskowski A, Hindley N, McDonald B, Molyneux. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet. 1994;343:829-830.
17. Tatemichi TK, Sacktor N, Mayeux R. Dementia associated with cerebrovascular disease, other degenerative diseases, and metabolic disorders. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer's Disease. New York, NY: Raven Press, Ltd; 1994:123-166.
18. Breteler MMB, van Amerongen NM, van Swieten JC, Claus JJ, Grobbee DE, van Gijn J, Hofman A, van Harskamp F. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging: the Rotterdam Study. Stroke. 1994;25:1109-1115.
19. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med. 1996;47:387-400.
20. Farrer LA, Cupples A, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pencak-Vance MA, Risch N, van Duijn CM, for the APOE and Alzheimer's Disease Meta Analysis Consortium. Effects of age, sex, and ethnicity on the association between apolipoprotein e genotype and Alzheimer's disease. JAMA. 1997;278:1349-1356.
21. Blacker D, Haines JL, Rodes L, Terwedow H, Go RCP, Harrell LE, Perry RT. Bassett SS, Chase G, Meyers D, Albert MS, Tanzi R. ApoE-4 and age at onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology. 1997;48:139-147.
22. Hofman A, Ott A, Breteler MMB, Bots ML, Slotter AJC, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154.
23. Fried LP, Borhani NO, Ennght P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB. New-man A, O'Leary DH, Psaty B. Rautaharju P, Tracy RP, Weiler PG, for the Cardiovascular Health Study Research Group (CHS): the Cardiovascular Health Study: Design and rationale. Ann Epidemiol. 1991;1:263-276.
24. Salthouse TA. The role of memory in the age decline in digit symbol substitution performance. J Gerontol. 1978;33:232-238.
25. Commenges D, Gagnon M, Letenneur L, Dartigues JF, Barberger-Gateau P, Salamon R. Improving screening for dementia in the elderly using Mini-Mental State Examination subscores, Benton's visual retention test, and Isaacs' set test. Epidemiology. 1992;3:185-188.
26. Bryan RN, Wells SW, Miller TJ, Elster AD, Jungreis CA, Poirier VC, Lind BK, Manolio TA. Infarct-like lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly: data from the Cardiovascular Health Study. Radiology. 1997;202:47-54.
27. Yue NC, Arnold AM, Longstreth WT, Elster AD, Jungreis CA, O'Leary DH, Poirier VC, Bryan N. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the Cardiovascular Health Study. Radiology. 1997;202:33-39.
28. Manoho TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Gardin JM, Fried LP, Steinberg EP, Bryan RN, for the Cardiovascular Health Study Collaborative Research Group. Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke. 1994;25:318-327.
29. Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L, for the Cardiovascular Health Study Collaborative Research Group. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke. 1996;27:1274-1282.
30. Austin M, Ordovas J, Eckfeld J, Tracy R, Boerwinkle E, Lalouel J-M, Printz M. Guidelines of the National Heart, Lung, and Blood Institute Working Group on Blood Drawing, Processing and Storage for Genetic Studies. Am J Epidemiol. 1996;144:437-441.
31. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545-548.
32. Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O'Leary D, Psaty B, Robbins J. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 1994;139:1164-1179.
33. Hosmer DW, Lemeshow S. Applied Logistic Regression. Philadelphia: John Wiley & Sons, Inc; 1989.
34. Cauley JA, Eichner JE, Kamboh MI, Ferrell RE, Kuller LH. Apo E allele frequencies in younger (age 42-50) vs older (65-90) women. Genetic Epidemiol. 1993;10:27-34.
35. Hyman BT, Gomez-Isla T, Briggs M, Chung H, Nichols S, Kohout F, Wallace R. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol. 1996;40:55-66.
36. APA. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:886.
37. Consensus Development Panel. Office of Medical Application of Research, National Institutes of Health: differential diagnosis of dementing diseases. JAMA. 1987;258:3411-3416.
38. Ganguli M, Belle S, Ratcliff G, Seaberg E, Hoff FJ, von der Porten K, Kuller LH. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: the MoVIES Project. J Gerontol. 1993; 48:M152-M161.
39. Breitner JCS. New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause. Neurobiol Aging. 1994;15: S175-S177.
40. White L, Petrovitch H, Ross GW, Masaki KH, Abbott RD, Teng EL, Rodriguez BL, Blanchette PL, Havlik RJ, Wergowske G, Chiu D, Foley DJ, Murdaugh C, Curb JD. Prevalence of dementia in older Japanese-American men in Hawaii: the Honolulu-Asia Aging Study. JAMA. 1996; 276:955-960.
41. White L, Katzman R, Losonczy K, Salive M, Wallace R, Berkman L, Taylor J, Fillenbaum G, Havlik R. Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. J Clin Epidemiol. 1994;47:363-374.
42. Butler SM, Ashford JW, Snowdon DA. Age, education, and changes in the mini-mental state exam scores of older women: findings from the NUN Study. J Am Geriatr Soc. 1996;44:675-681.
43. Stem Y, Gurland B, Tatenuchi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994;271:1004-1010.
44. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology. 1995;45:1707-1712.
45. Mortimer JA, Graves AB. Education and other socioeconomic determinants of dementia and Alzheimer's disease. Neurology. 1993;43:S39-S44.
46. Mortimer JA. What are the risk factors for dementia? In: Huppert FA, Brayne C, O'Connor DW, eds. Dementia and Normal Aging. New York: Cambridge University Press; 1994:208-229.
47. Teresi JA, Golden RR, Cross P, Gurland B, Kleinman M, Wilder D. Item bias in cognitive screening measures: comparisons of elderly white, Afro-American, Hispanic and high and low education subgroups. J Clin Epidemiol. 1995;48:473-483.
48. Henderson AS, Sartonus N. International criteria and differential diagnosis. In: Huppert FA, Brayne C. O'Connor DW, eds. Dementia and Normal Aging. New York: Cambridge University Press; 1994:79-90.
49. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the NUN Study. JAMA. 1997;277:813-817.
50. Tatemichi TK. How acute brain failure becomes chronic: a view of the mechanisms of dementia related to stroke. Neurology. 1990;40:1652-1659.
51. Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stem Y, Sano M, Reimen RH, Williams JBW, Mohr JP, Hauser WA, Figueroa M. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992;42:1185-1193.
52. Ferrucci L, Guralnik JM, Salive ME, Pahor M, Corti M-C, Baroni A, Havlik RJ. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc. 1996;44:237-241.
53. Breteler MMB, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994;308:1604-1608.
54. Tierney MC, Szalai JP, Snow WG, Fisher RH, Tsuda T, Chi H, McLachlan DR, St. George-Hyslop PH. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology. 1996;46:149-154.
55. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N Engl J Med. 1996;334:752-758.
56. Reed T, Carmelli D, Swan GE, Breitner JCS, Welsh KA, Jarvik GP, Deeb S, Auwerx J. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Arch Neurol. 1994;51: 1189-1192.
57. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA. 1994;272:1666-1671.
58. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 1993;71:160-165.
59. Kosunen O, Talasniemi S, Lehtovirta M, Hemonen O, Helisalmi S, Mannermaa A, Paljarvi L, Ryynanen M. Riekkinen PJ, Soinnen H. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke. 1995;26:743-748.
60. Slotter AJC, Tang MX, van Duijn CM, Stem Y, Ott A, Bell K, Breteler MMB, Van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R. Apolipoprotein E ε4 and the risk of dementia with stroke: a population-based investigation. JAMA. 1997;277:818-821.
61. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Cerebrovascular disease, the apolipoprotein E4 allele, and cognitive decline in a community-based study of elderly men. Stroke. 1996;27:2230-2235.
62. Canadian Study of Health, and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc. 1994;150:899-913.
63. Lindsay J, Hebert R, Rockwood K. The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke. 1997;28:526-530.
64. Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, Sugimoto K, Yamaguchi T, Sasaki H, Chiu D, White LR. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6:45-58.
65. Galanis DJ, Petrovitch H, Launer LJ, Harris TB, Foley DJ, White LR. Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American Men. Am J Epidemiol. 1997;145:507-515.
66. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-765.
67. Giumbra L, Arenberg D, Zonderman A, Kawas C, Costa P. Adult lifespan changes in immediate visual memory and verbal intelligence. Psychol Aging. 1995;10:123-139.
68. Howieson DB, Dame A, Camicioli R, Sexton G, Payami H, Kaye JA. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc. 1997;45:584-589.
69. Kukull WA, Larson EB, Teri L, Bowen J, McCormick W, Pfanschmidt ML. The Mini-Mental State Examination score and the clinical diagnosis of dementia. J Clin Epidemiol. 1994;47:1061-1067.
70. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.